Hyoscine hydrobromide
Pharmaceutical forms
Suppository
Country lists
ATC N/A
Composition 10 mg
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Tablet
Country lists
ATC N/A
Composition 20 mg
Observations for this pharmaceutical form can be found on the lists:
Chile
Essential and Prioritized Medications
  • No observations
Suppository
Country lists
ATC N/A
Composition 20 mg
Observations for this pharmaceutical form can be found on the lists:
Chile
Essential and Prioritized Medications
  • No observations
Injection
Country lists
ATC N/A
Composition 400 mcg/mL
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.4. Medicines used in palliative care
  • This medicine is only for children.
Injection
Country lists
ATC N/A
Composition 600 mcg/mL
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.4. Medicines used in palliative care
  • This medicine is only for children.
Transdermal patches
Country lists
ATC N/A
Composition 1 mg/72 hours
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
8.4. Medicines used in palliative care
  • This medicine is only for children.
Injection
Country lists
ATC N/A
Composition 0.02 g + 2.5 g dipyrone in 5mL
Observations for this pharmaceutical form can be found on the lists:
Colombia
06.3 Anti-Spasmodics
  • No observations
Injection
Country lists
ATC N/A
Composition 20 mg in 1-mL ampoule
Tablet
Country lists
ATC N/A
Composition 10 mg
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
17.4 Anti-Spasmodics
  • No observations
Colombia
06.3 Anti-Spasmodics
  • No observations
Solution (eye drops)
Country lists
ATC N/A
Composition 0.1%
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Injection
Country lists
ATC N/A
Composition 20 mg/mL
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
17.4 Anti-Spasmodics
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Colombia
06.3 Anti-Spasmodics
  • No observations